136 related articles for article (PubMed ID: 20080287)
1. Lack of pharmacodynamic interaction of silodosin, a highly selective alpha1a-adrenoceptor antagonist, with the phosphodiesterase-5 inhibitors sildenafil and tadalafil in healthy men.
MacDiarmid SA; Hill LA; Volinn W; Hoel G
Urology; 2010 Mar; 75(3):520-5. PubMed ID: 20080287
[TBL] [Abstract][Full Text] [Related]
2. Hemodynamic interaction between a daily dosed phosphodiesterase 5 inhibitor, tadalafil, and the alpha-adrenergic blockers, doxazosin and tamsulosin, in middle-aged healthy male subjects.
Guillaume M; Lonsdale F; Darstein C; Jimenez MC; Mitchell MI
J Clin Pharmacol; 2007 Oct; 47(10):1303-10. PubMed ID: 17906163
[TBL] [Abstract][Full Text] [Related]
3. Pharmacology and drug interaction effects of the phosphodiesterase 5 inhibitors: focus on alpha-blocker interactions.
Kloner RA
Am J Cardiol; 2005 Dec; 96(12B):42M-46M. PubMed ID: 16387566
[TBL] [Abstract][Full Text] [Related]
4. Safety of intravenous nitroglycerin after administration of sildenafil citrate to men with coronary artery disease: a double-blind, placebo-controlled, randomized, crossover trial.
Parker JD; Bart BA; Webb DJ; Koren MJ; Siegel RL; Wang H; Malhotra B; Jen F; Glue P
Crit Care Med; 2007 Aug; 35(8):1863-8. PubMed ID: 17522570
[TBL] [Abstract][Full Text] [Related]
5. Hemodynamic interaction study between the alpha1-blocker alfuzosin and the phosphodiesterase-5 inhibitor tadalafil in middle-aged healthy male subjects.
Giuliano F; Kaplan SA; Cabanis MJ; Astruc B
Urology; 2006 Jun; 67(6):1199-204. PubMed ID: 16765179
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of sildenafil citrate (Viagra) and tadalafil (Cialis) on sexual responses in Saudi men with erectile dysfunction in routine clinical practice.
Ali ST
Pak J Pharm Sci; 2008 Jul; 21(3):275-81. PubMed ID: 18614424
[TBL] [Abstract][Full Text] [Related]
7. Silodosin and tadalafil have synergistic inhibitory effects on nerve-mediated contractions of human and rat isolated prostates.
Buono R; Briganti A; Freschi M; Villa L; La Croce G; Moschini M; Benigni F; Castiglione F; Montorsi F; Hedlund P
Eur J Pharmacol; 2014 Dec; 744():42-51. PubMed ID: 25261033
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with preference for sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy: post hoc analysis of data from a multicentre, randomized, open-label, crossover study.
Eardley I; Montorsi F; Jackson G; Mirone V; Chan ML; Loughney K; Vail GM; Beardsworth A
BJU Int; 2007 Jul; 100(1):122-9. PubMed ID: 17552960
[TBL] [Abstract][Full Text] [Related]
9. Sildenafil citrate and blood-pressure-lowering drugs: results of drug interaction studies with an organic nitrate and a calcium antagonist.
Webb DJ; Freestone S; Allen MJ; Muirhead GJ
Am J Cardiol; 1999 Mar; 83(5A):21C-28C. PubMed ID: 10078539
[TBL] [Abstract][Full Text] [Related]
10. Acute effects of a single dose of phosphodiesterase type 5 inhibitor (sildenafil) on systemic arterial blood pressure during exercise and 24-hour ambulatory blood pressure monitoring in heart transplant recipients.
Guimaraes GV; d'Avila VM; Pires P; Bacal F; Stolf N; Bocchi E
Transplant Proc; 2007 Dec; 39(10):3142-9. PubMed ID: 18089340
[TBL] [Abstract][Full Text] [Related]
11. Alterations in sperm motility after acute oral administration of sildenafil or tadalafil in young, infertile men.
Pomara G; Morelli G; Canale D; Turchi P; Caglieresi C; Moschini C; Liguori G; Selli C; Macchia E; Martino E; Francesca F
Fertil Steril; 2007 Oct; 88(4):860-5. PubMed ID: 17544419
[TBL] [Abstract][Full Text] [Related]
12. A multicenter, randomized, double-blind, crossover study to evaluate patient preference between tadalafil and sildenafil.
von Keitz A; Rajfer J; Segal S; Murphy A; Denne J; Costigan T; Lockhart D; Beasley CM; Emmick JT
Eur Urol; 2004 Apr; 45(4):499-507; discussion 507-9. PubMed ID: 15041116
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous administration of vardenafil and tamsulosin does not induce clinically significant hypotension in patients with benign prostatic hyperplasia.
Auerbach SM; Gittelman M; Mazzu A; Cihon F; Sundaresan P; White WB
Urology; 2004 Nov; 64(5):998-1003; discussion 1003-4. PubMed ID: 15533493
[TBL] [Abstract][Full Text] [Related]
14. Acute effects of sildenafil on flow mediated dilatation and cardiovascular autonomic nerve function in type 2 diabetic patients.
Stirban A; Laude D; Elghozi JL; Sander D; Agelink MW; Hilz MJ; Ziegler D
Diabetes Metab Res Rev; 2009 Feb; 25(2):136-43. PubMed ID: 19116943
[TBL] [Abstract][Full Text] [Related]
15. The effects of three phosphodiesterase type 5 inhibitors on ejaculation latency time in lifelong premature ejaculators: a double-blind laboratory setting study.
Gökçe A; Halis F; Demirtas A; Ekmekcioglu O
BJU Int; 2011 Apr; 107(8):1274-7. PubMed ID: 21929518
[TBL] [Abstract][Full Text] [Related]
16. Hemodynamic effects of once-daily tadalafil in men with signs and symptoms of benign prostatic hyperplasia on concomitant α1-adrenergic antagonist therapy: results of a multicenter randomized, double-blind, placebo-controlled trial.
Goldfischer E; Kowalczyk JJ; Clark WR; Brady E; Shane MA; Dgetluck N; Klise SR
Urology; 2012 Apr; 79(4):875-82. PubMed ID: 22341603
[TBL] [Abstract][Full Text] [Related]
17. Differential vasoactive effects of sildenafil and tadalafil on cerebral arteries.
Kruuse C; Gupta S; Nilsson E; Kruse L; Edvinsson L
Eur J Pharmacol; 2012 Jan; 674(2-3):345-51. PubMed ID: 22094063
[TBL] [Abstract][Full Text] [Related]
18. Effect of sildenafil on blood pressure and arterial wave reflection in treated hypertensive men.
Mahmud A; Hennessy M; Feely J
J Hum Hypertens; 2001 Oct; 15(10):707-13. PubMed ID: 11607801
[TBL] [Abstract][Full Text] [Related]
19. Comparative relaxing effects of sildenafil, vardenafil, and tadalafil in human corpus cavernosum: contribution of endogenous nitric oxide release.
Toque HA; Priviero FB; Teixeira CE; Claudino MA; Baracat JS; Fregonesi A; De Nucci G; Antunes E
Urology; 2009 Jul; 74(1):216-21. PubMed ID: 19371941
[TBL] [Abstract][Full Text] [Related]
20. Urodynamic effects of once daily tadalafil in men with lower urinary tract symptoms secondary to clinical benign prostatic hyperplasia: a randomized, placebo controlled 12-week clinical trial.
Dmochowski R; Roehrborn C; Klise S; Xu L; Kaminetsky J; Kraus S
J Urol; 2010 Mar; 183(3):1092-7. PubMed ID: 20092847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
